Cogint subsidiary acquires minority interest in Dragonchain [Seeking Alpha]
Cogent Biosciences, Inc. (COGT)
Last cogent biosciences, inc. earnings: 11/8 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.cogint.com/investor-relations
Company Research
Source: Seeking Alpha
Cogint subsidiary acquires minority interest in DragonchainCogint's (COGT+1.7%) subsidiary, Red Violet Blockchain and Analytical Solutions, LLC,has acquired a minority interest (~ less then 5%) in Seattle-based Dragonchain. Terms of the transaction were not disclosed.“We believe that Dragonchain’s technology is uniquely positioned to drive significant enterprise adoption,” commented Derek Dubner, CEO of cogint. “We invested in Dragonchain because of its valuable technology, thought leadership, cultural alignment, and opportunity to be the leader in enterprise blockchain adoption across disparate industries.”Previously:Cogint to accelerate blockchain spin-off; insider buys $293K worth (Feb. 13)Click to subscribe to real-time analytics on COGTNow read:Publicis: Valuation Discount Is Unwarranted »
Show less
Read more
Impact Snapshot
Event Time:
COGT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COGT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COGT alerts
High impacting Cogent Biosciences, Inc. news events
Weekly update
A roundup of the hottest topics
COGT
News
- Cogent Biosciences, Inc. (NASDAQ: COGT) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.MarketBeat
- COGT Reports Full Year 2023 Financial Results and Business Highlights [Yahoo! Finance]Yahoo! Finance
- Cogent Biosciences, Inc. (NASDAQ: COGT) had its price target raised by analysts at JPMorgan Chase & Co. from $18.00 to $20.00. They now have an "overweight" rating on the stock.MarketBeat
- Cogent Biosciences, Inc. (NASDAQ: COGT) had its price target raised by analysts at Citigroup Inc. from $11.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
COGT
Earnings
- 8/8/23 - Miss
COGT
Sec Filings
- 3/27/24 - Form SC
- 3/22/24 - Form 8-K
- 2/26/24 - Form S-8
- COGT's page on the SEC website